The effects of inhaled corticosteroid on insulin sensitivity in asthmatic patients.

Asthma is an inflammatory disease, which causes airflow limitation and increase insulin resistance. The present study was carried out in order to investigate insulin resistance and the effect of inhaled corticosteroid (ICS) on insulin sensitivity in asthmatic patients. A registered (IRCT201605247411N2) interventional, quasi-experimental trial was performed from 2014 to 2015 in Imam Khomeini hospital Ahvaz, Iran. Patients with mild to moderate asthma participated in this study. Spirometry, fasting blood sugar (FBS), blood sugar 2 hour post prandial (BS2HPP), HbA1C, low density lipoprotein (LDL), high density lipoprotein (HDL), Insulin Level, and C reactive protein (CRP) were measured. Then Homeostatic Model Assessment-Insulin Resistance [HOMA-IR] Index calculated. Data were analyzed using paired t-test and McNemar's test using SPSS 20.0 Software. The study consisted of 35 non-diabetic patients suffering from asthma (20 men and 15 women) with a mean age of 36.6 ±12.3 years. Inhaled corticosteroid had a significant effect on spirometric parameters, but it had no significant effect on other variables. At baseline, mean HbA1C, insulin level and HOMA-IR were 5.5%, 10.9 mIU/L and 2.7 respectively. None of these values changed significantly after treatment with inhaled corticosteroid for two months. The results indicated that there is no relationship between ICS and increased insulin resistance in asthmatic patients.

[1]  Zahra Rahimi,et al.  A cross-sectional study of prevalence and risk factors for childhood asthma in Ahvaz city, Iran , 2015, Postepy dermatologii i alergologii.

[2]  M. Kabesch,et al.  Asthma and endocrine disorders: Shared mechanisms and genetic pleiotropy , 2011, Molecular and Cellular Endocrinology.

[3]  S. Suissa,et al.  Inhaled corticosteroids and the risks of diabetes onset and progression. , 2010, The American journal of medicine.

[4]  W. Kuschner,et al.  The Effect of an Inhaled Corticosteroid on Glucose Control in Type 2 Diabetes , 2009, Clinical Medicine & Research.

[5]  D. Au,et al.  The association of inhaled corticosteroid use with serum glucose concentration in a large cohort. , 2009, The American journal of medicine.

[6]  A. Linneberg,et al.  Insulin resistance as a predictor of incident asthma‐like symptoms in adults , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[7]  Naresh M Punjabi,et al.  Effects of acute intermittent hypoxia on glucose metabolism in awake healthy volunteers. , 2009, Journal of applied physiology.

[8]  Aynur Gulcan,et al.  Evaluation of Glucose Tolerance Status in Patients with Asthma Bronchiale , 2009, The Journal of asthma : official journal of the Association for the Care of Asthma.

[9]  G. Can,et al.  Effects of inhaled budesonide on insulin sensitivity in nondiabetic patients with asthma and chronic obstructive pulmonary disease , 2007, Advances in therapy.

[10]  JoAnn E Manson,et al.  Chronic obstructive pulmonary disease, asthma, and risk of type 2 diabetes in women. , 2004, Diabetes care.

[11]  R. Bergman,et al.  Insulin sensitivity, insulinemia, and coronary artery disease: the Insulin Resistance Atherosclerosis Study. , 2004, Diabetes care.

[12]  J. Hux,et al.  Quantification of the risk of corticosteroid-induced diabetes mellitus among the elderly , 2002, Journal of general internal medicine.

[13]  N. Dendukuri,et al.  Inhaled corticosteroids and the risk of diabetes among the elderly. , 2002, British journal of clinical pharmacology.

[14]  M. Turpeinen,et al.  Effect of eight months of inhaled beclomethasone dipropionate and budesonide on carbohydrate metabolism in adults with asthma. , 1993, Thorax.

[15]  R. Sorva,et al.  Changes in carbohydrate and lipid metabolism in children with asthma inhaling budesonide. , 1991, The Journal of allergy and clinical immunology.

[16]  J. Yernault,et al.  The endocrinometabolic effects of beclomethasone dipropionate in asthmatic patients. , 1977, Chest.